Quarterly Report • Feb 26, 2023
Quarterly Report
Open in ViewerOpens in native device viewer

EASE
Hod Hasharon (Israel) 26 February 2023 - Singapore Exchange Mainboard and Tel Aviv Exchange listed Sarine Technologies Ltd ("Sarine" and along with its subsidiaries "the Group") (U77:SI; SARN.TA), a worldwide leader in the development, manufacturing, marketing and sale of precision technology products for the evaluation, planning, processing, measurement, grading and trading of diamonds and gems, is pleased to update its business results for the year ended 31 December 2022.
Market conditions were challenging throughout most of FY2022. Negative geopolitical developments, commencing with the onset of the war in Ukraine, an inflationary economic environment with dramatically increasing interest rates and the zero-Covid policy related lockdowns in China resulted in equity market and housing value losses. Consequently, household wealth was eroded in many key markets, and the overall negative effect on consumer confidence impaired business conditions in the discretionary diamond jewellery value chain.


In addition, the price increases of rough diamonds throughout 2022 by a cumulative average of 35%, primarily due to the fear of disrupted supplies of rough diamonds from U.S. sanctioned Russian producer Alrosa, combined with the gradual decline in the prices of polished diamonds in 2022 as consumer sentiment worsened, resulted in impaired margins in the polishing segment and a higher inventory of polished diamonds. This reduced the level of diamond manufacturing in Q4 2022 in general, and especially so for the larger more expensive rough stones. With reduced manufacturing, the Group's revenue from Galaxy® scanning was lower in H2 2022.
Despite these challenges, Group revenue rose 5.5% to US\$27.6 million in H2 2022 mainly on higher sales of capital equipment due to the successful roll-out in September of the upgraded Meteorite™ Plus, which significantly improves throughput and reduces the necessary operational manpower. However, full year FY2022 revenue declined 5% compared to FY2021 due to a high base in H1 2021, caused by a post-Covid spike in jewellery spendings in the U.S. coinciding with widespread cash handouts by the federal and state governments.
With lower revenue and a change in product mix, gross margin in FY2022 declined to 69%. The product mix effect was mainly due to the rollout of the lower-margin Meteorite™ Plus. Profitability was further affected with the overall increase in operating expenses as activities returned to normal in a post Covid era, and higher tax expenses associated with a one-time repatriation of funds from the Group's wholly owned Indian subsidiary.
A total of 61 Galaxy® -family inclusion mapping systems were delivered in H2 2022, comprising 2 Galaxy® Ultra models, 5 Galaxy® models, 8 Meteor™ models and 46 Meteorite™ and Meteorite™ plus models. Only one Meteor™ systems was sold under the one-off paradigm with no follow-on per-use revenues. With the latest deliveries, our installed base has increased to 803 systems as at 31 December 2022. Despite lower inclusion scanning revenues in H2 2022, overall recurring revenues rose to 50% of Group revenue in FY2022, as compared to 46% in FY2021. Trade revenues, the new sources of recurring revenues, continued to grow strongly in FY2022 to account for about 11% of Group revenue.
The Board of Directors has declared a final dividend of US 1.0 cent, the third dividend for FY2022. With three dividends, the Group will have paid out about US\$10.5 million in FY2022 (US\$ 8.8 million in FY2021), exceeding somewhat the net profit of the Group for the full year.
Geopolitical uncertainties are expected to continue into 2023. There is little end in sight for the conflict in Ukraine and with inflation lower, but still not tamed, global interest rates will stay elevated and could rise further in the months ahead. These uncertainties will continue to affect sentiments and demand for jewelery in the United States. Howeverm a bright spot is the abrupt end of the zero-Covid policy in China rebooting demand for polished diamonds in this important market.


The divergence of rough and polished diamond prices especially in the latter part of 2022 eroded polishers' margins and with the weaker than expected year end holiday buying in the United States, inventories of polished diamonds rose to higher than usual levels. Rough diamond prices have now started declining in certain categories (DeBeers cut prices of larger stones by 10% at their January sight), and with the expected return of Chinese buyers to add to demand, this divergence could normalise in 2023. We expect the level of manufacturing in the midstream to increase in the coming months.
The continuing adoption of our Sarine Diamond Journey™ provenance and traceability solution by leading luxury brands and key industry players have strengthened our position as the only viable scalable solution for end-to-end diamond provenance based on actual data and not just selfdeclarations and sporadic audits. As environmental, social and governance (ESG) issues are becoming core considerations with consumers and investors, we expect the current pool of retailers in the key US, Chinese and other markets who are currently evaluating and executing pilot pragrammes of our solution to increase.
As the conflict in Ukraine enters its second year, the U.S. is reportedly looking to tighten its sanctions on Russian diamonds. It is expected that the proviso that allowed the importation into the U.S. of Russian-mined diamonds cut and polished elsewhere (e.g., India) will be eliminated. It is apparent that the E.U. and the U.S. are aiming to develop a "'watertight' traceability system" for diamonds as a way to preclude any importation of Russian gems. "The Belgium government has suggested an international traceability requirement," reported Tom Neys, spokesperson for Antwerp World Diamond Centre, a key Belgian industry group. Their proposal would mean that every company who wants access to the U.S., E.U., and other G-7 markets would need to provide definitive ("watertight") provenance information. We are confident that the Sarine AutoScan™, our robotic system for the high-speed scanning of rough stones, which provides the capability to economically document the extraction of rough diamonds at their mined source, and the rough stones' subsequent traceability by our Sarine Diamond Journey™, can provide the entire value chain with the means with which to fully and transparently comply with these new government requirements with minimal disruption. A faster version of the Sarine AutoScan™, which will also handle smaller rough stones economically, is already in alpha-testing and will make our solution's ability to meet these new government statutes even more robust.
We continue to generate strong interest in our e-Grading™ as our broader roll-out to midstream customers, both for natural and lab-grown diamonds, continues. We are seeing more retail brands adopting our AI-derived grading platform and expect our planned acquisition and cooperation with the New-York based GCAL lab to accelerate the process of market penetration into the U.S. market.
This press release should be read in conjunction with Sarine's full year FY2022 results announcement released on 26 February 2023 to the Singapore Exchange.


Established in 1988, Sarine Technologies Ltd. is a worldwide leader in the development and manufacturing of advanced modeling, analysis, evaluation, planning, processing, finishing, grading and trading systems for diamonds. Sarine products include the Galaxy® family of inclusion and tension mapping systems, rough diamond planning and optimisation technologies, laser cutting and shaping tools, laser-marking, inscription and fingerprinting equipment, automated (AI-derived) Clarity, Color, Cut and light performance grading systems and traceability, visualisation and retailing services. Sarine systems have become standard tools in every modern manufacturing plant, properly equipped gemology lab and diamond appraisal business, and are essential aids for diamond polishers, dealers and retailers. For more information about Sarine and its products and services, visit http://www.sarine.com
APAC IR Cyrus Capital Consulting Mr. Lee Teong Sang Tel: +65-9633 9035 [email protected] Sarine Technologies Ltd. Marketing & Communications Ms. Romy Gakh-Baram Tel: +972-9-7903500 [email protected]

| Table of Contents | |||||
|---|---|---|---|---|---|
| A. Condensed Consolidated and Company Statements of Financial Position | 1 | ||||
| B. Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income |
2 | ||||
| C. Condensed Consolidated and Company Statements of Changes in Equity | 3 | ||||
| D. Condensed Consolidated Statements of Cash Flows | 4 | ||||
| E. Notes to the Condensed Interim Financial Statements | 5 | ||||
| F. Other Information Required by Listing Rule 7.2 | 11 |
| Group | Company | |||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| US\$ thousands | ||||
| Assets | ||||
| Property, plant and equipment | 10,431 | 11,348 | 1,395 | 1,199 |
| Right-of-use assets | 3,918 | 4,719 | 3,751 | 4,450 |
| Intangible assets | 2,051 | 2,244 | 70 | 138 |
| Long-term trade receivables | 1,006 | 700 | 653 | 89 |
| Investment in subsidiaries | -- | -- | 36,022 | 46,308 |
| Long-term income tax receivable | 500 | 500 | -- | -- |
| Deferred tax assets | 499 | 573 | -- | -- |
| Total non-current assets | 18,405 | 20,084 | 41,891 | 52,184 |
| Inventories | 6,859 | 7,280 | 4,388 | 3,544 |
| Trade receivables | 21,476 | 23,061 | 6,733 | 7,154 |
| Other current assets | 2,496 | 1,601 | 1,553 | 669 |
| Short-term investments (bank deposits) | 10,684 | 9,055 | 9,627 | 7,017 |
| Cash and cash equivalents | 25,307 | 27,358 | 17,216 | 13,128 |
| Total current assets | 66,822 | 68,355 | 39,517 | 31,512 |
| Total assets | 85,227 | 88,439 | 81,408 | 83,696 |
| Equity | ||||
| Share capital* | -- | -- | -- | -- |
| Share premium and reserves | 34,490 | 34,014 | 34,490 | 34,014 |
| Translation reserve | (4,217) | (2,896) | (4,217) | (2,896) |
| Dormant shares, at cost | (4,829) | (3,935) | (4,829) | (3,935) |
| Retained earnings | 41,652 | 43,368 | 41,652 | 43,368 |
| Total equity | 67,096 | 70,551 | 67,096 | 70,551 |
| Liabilities | ||||
| Long-term lease liabilities | 3,557 | 4,743 | 3,524 | 4,625 |
| Employee benefits | 194 | 275 | 184 | 264 |
| Total non-current liabilities | 3,751 | 5,018 | 3,708 | 4,889 |
| Trade payables | 3,220 | 2,324 | 2,544 | 1,892 |
| Other payables | 8,064 | 7,735 | 7,139 | 5,408 |
| Current lease liabilities | 812 | 974 | 682 | 722 |
| Current tax payable | 1,925 | 1,504 | -- | -- |
| Warranty provision | 359 | 333 | 239 | 234 |
| Total current liabilities | 14,380 | 12,870 | 10,604 | 8,256 |
| Total liabilities | 18,131 | 17,888 | 14,312 | 13,145 |
| Total equity and liabilities | 85,227 | 88,439 | 81,408 | 83,696 |
* No par value
| Group Six Months Ended December 31, |
Group Year ended December 31, |
|||||
|---|---|---|---|---|---|---|
| 2022 US\$ thousands |
2021 | change % |
2022 US\$ thousands |
2021 | change % |
|
| Revenue | 27,591 | 26,153 | 5.5 | 58,763 | 62,116 | (5.4) |
| Cost of Sales | (9,209) | (7,174) | 28.4 | (18,140) | (16,289) | 11.4 |
| Gross profit | 18,382 | 18,979 | (3.1) | 40,623 | 45,827 | (11.4) |
| Research and development expenses | (4,481) | (4,180) | 7.2 | (8,675) | (8,099) | 7.1 |
| Sales and marketing expenses | (6,168) | (5,651) | 9.1 | (12,425) | (11,038) | 12.6 |
| General and administrative expenses | (4,236) | (3,980) | 6.4 | (8,525) | (7,754) | 9.9 |
| Other income from lease termination | -- | -- | -- | 267 | NA | |
| Profit from operations | 3,497 | 5,168 | (32.3) | 10,998 | 19,203 | (42.7) |
| Net finance income (expense) | 264 | (328) | NA | 337 | (266) | NA |
| Profit before income tax | 3,761 | 4,840 | (22.3) | 11,335 | 18,937 | (40.1) |
| Income tax expense | 1,508 | 963 | 56.6 | 2,537 | 2,481 | 2.3 |
| Profit for the period | 2,253 | 3,877 | (41.9) | 8,798 | 16,456 | (46.5) |
| Other comprehensive income (loss) | ||||||
| Remeasurement of defined benefit plan | 50 | 24 | 108.3 | 50 | 24 | 108.3 |
| Foreign currency translation differences from foreign operations |
(574) | (5) | 11,380.0 | (1,321) | (197) | 570.6 |
| Total comprehensive income for the period |
1,729 | 3,896 | (55.6) | 7,527 | 16,283 | (53.8) |
| Earnings per share | ||||||
| Basic earnings per share (US cents) Diluted earnings per share (US cents) |
0.64 0.64 |
1.10 1.10 |
(41.8) (41.8) |
2.51 2.51 |
4.70 4.69 |
(46.6) (46.5) |
| Share capital* |
Share premium and reserves |
Translation reserve |
Retained earnings |
Dormant shares |
Total | |||
|---|---|---|---|---|---|---|---|---|
| Group and Company | US\$ thousands | |||||||
| Balance at January 1, 2021 | -- | 33,149 | (2,699) | 33,930 | (3,689) | 60,691 | ||
| Profit for the year ended December 31, 2021 |
-- | -- | -- | 16,456 | -- | 16,456 | ||
| Other comprehensive loss for the year ended December 31, 2021 |
-- | 24 | (197) | -- | -- | (173) | ||
| Dormant shares, acquired at cost (550,000 shares) |
-- | -- | -- | -- | (246) | (246) | ||
| Share-based payment expenses | -- | 382 | -- | -- | -- | 382 | ||
| Exercise of options | -- | 459 | -- | -- | -- | 459 | ||
| Dividend paid | -- | -- | -- | (7,018) | -- | (7,018) | ||
| Balance at December 31, 2021 | -- | 34,014 | (2,896) | 43,368 | (3,935) | 70,551 | ||
| Profit for the year ended December 31, 2022 |
-- | -- | -- | 8,798 | -- | 8,798 | ||
| Other comprehensive loss for the year ended December 31, 2022 |
-- | 50 | (1,321) | -- | -- | (1,271) | ||
| Dormant shares, acquired at cost (3,119,500 shares) |
-- | -- | -- | -- | (894) | (894) | ||
| Share-based payment expenses | -- | 264 | -- | -- | -- | 264 | ||
| Exercise of options | -- | 162 | -- | -- | -- | 162 | ||
| Dividend paid | -- | -- | -- | (10,514) | -- | (10,514) | ||
| Balance at December 31, 2022 | -- | 34,490 | (4,217) | 41,652 | (4,829) | 67,096 |
* No par value
| Group | ||
|---|---|---|
| 2022 | 2021 | |
| US\$ thousands | ||
| Cash flows from operating activities | ||
| Profit for the year | 8,798 | 16,456 |
| Adjustments for: | ||
| Share-based payment expenses | 264 | 382 |
| Income tax expense | 2,537 | 2,481 |
| Depreciation of property, plant & equipment and right-of-use assets | 2,380 | 2,684 |
| Amortisation of intangible assets | 193 | 319 |
| Net finance expense | 169 | 127 |
| Revaluation of lease liabilities from exchange rate differences | (630) | 40 |
| Revaluation of bank financing liabilities from exchange rate differences | -- | (32) |
| Changes in working capital | ||
| Inventories | 421 | (1,033) |
| Trade receivables | 1,279 | (952) |
| Other current assets | (895) | (10) |
| Trade payables | 896 | 456 |
| Other liabilities | (391) | 1,540 |
| Employee benefits | (81) | 32 |
| Income tax paid | (2,042) | (1,361) |
| Net cash from operating activities | 12,898 | 21,129 |
| Cash flows used in investing activities | ||
| Acquisition of property, plant and equipment | (986) | (895) |
| Proceeds from realisation of property, plant and equipment | 51 | 138 |
| Short-terms investments, net | (1,629) | (2,752) |
| Restricted short-term investments (bank deposits) | -- | 171 |
| Interest received | 388 | 80 |
| Net cash used in investing activities | (2,176) | (3,258) |
| Cash flows used in financing activities | ||
| Proceeds from exercise of share options | 162 | 459 |
| Purchase of Company's shares by the Company | (894) | (246) |
| Repayment of bank financing | -- | (3,389) |
| Dividends paid | (10,514) | (7,018) |
| Payment of lease liabilities | (970) | (1,193) |
| Interest paid | (150) | (218) |
| Net cash used in financing activities | (12,366) | (11,605) |
| Net (decrease) increase in cash and cash equivalents | (1,644) | 6,266 |
| Cash and cash equivalents at beginning of year | 27,358 | 21,081 |
| Effect of exchange rate fluctuations on cash and cash equivalents | (407) | 11 |
| Cash and cash equivalents at end of year | 25,307 | 27,358 |
Sarine Technologies Ltd. (hereinafter "Sarine" or the "Company") is a company domiciled in Israel. The address of the Company's registered office is 4 Haharash Street, Hod Hasharon 4524075, Israel. The condensed interim financial statements of the Company, as at, December 31, 2022 and for the six months and year ended December 31, 2022, comprise the Company and its subsidiaries (together referred to as the "Group" and individually as "Group entities"). The Company was incorporated on November 8, 1988. On April 8, 2005, the Company was admitted to the Main Board list of the Singapore Exchange Securities Trading Ltd. and on July 5, 2021, the Company dual listed its shares for trading on the Tel Aviv Stock Exchange.
The condensed interim financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS). The condensed interim financial statements for the six months and year ended December 31, 2022 have been prepared in accordance with IAS 34 Interim Financial Reporting.
The condensed interim financial statements were authorised for issue by the Company's Board of Directors on February 26, 2023.
The condensed interim financial statements have been prepared on the historical cost basis except for the following material items in the condensed interim statement of financial position:
These condensed interim financial statements are presented in United States (US) dollars, or US\$, which is the Company's functional currency. The US dollar is the currency that represents the principal economic environment in which the Company and most Group entities operate. All financial information presented in US dollars has been rounded to the nearest thousand, except where otherwise indicated.
The preparation of condensed interim financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Certain accounting estimates used in the preparation of the Group's condensed interim financial statements may require management to make assumptions regarding circumstances and events that involve considerable uncertainty. Management prepares these estimates on the basis of past experience, known facts, external circumstances, and reasonable assumptions. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.
The accounting policies applied in these condensed interim financial statements for the six months and year ended December 31, 2022 are the same as those applied by the Company in audited financial statements for the year ended December 31, 2021.
The Group is a worldwide leader in the development, manufacturing, marketing and sale of precision technology products for the planning, processing, evaluation and measurement of diamonds and gems. India is the principal market for these products. In accordance with IFRS 8, the Group determines and presents operating segments based on the information that is provided internally to the CEO, who is the Group's chief operating decision maker. The measurement of operating segment results is generally consistent with the presentation of the Group's condensed interim statements of comprehensive income. The Group operates in only one operating segment. Presented below are revenues broken out by geographic distribution (India, Africa, Europe, USA, Israel and Other).
| Group | ||||||
|---|---|---|---|---|---|---|
| Six months ended December 31, | ||||||
| US\$ thousands | ||||||
| Region | 2022 | 2021 | \$ change | % | ||
| India | 14,362 | 15,394 | (1,032) | (6.7) | ||
| Africa | 6,706 | 3,620 | 3,086 | 85.2 | ||
| Europe | 1,402 | 778 | 624 | 80.2 | ||
| USA | 308 | 862 | (554) | (64.3) | ||
| Israel | 1,475 | 1,400 | 75 | 5.4 | ||
| Other* | 3,338 | 4,099 | (761) | (18.6) | ||
| Total | 27,591 | 26,153 | 1,438 | 5.5 |
| Group Year ended December 31, |
||||
|---|---|---|---|---|
| US\$ thousands | ||||
| Region | 2022 | 2021 | \$ change | % |
| India | 30,309 | 40,540 | (10,231) | (25.2) |
| Africa | 13,692 | 8,171 | 5,521 | 67.6 |
| Europe | 3,502 | 1,858 | 1,644 | 88.5 |
| USA | 842 | 1,115 | (273) | (24.5) |
| Israel | 2,227 | 2,653 | (426) | (16.1) |
| Other* | 8,191 | 7,779 | 412 | 5.3 |
| Total | 58,763 | 62,116 | (3,353) | (5.4) |
* Primarily Asia, excluding India
| Group | ||||
|---|---|---|---|---|
| Six months ended December 31, | Year ended December 31, | |||
| US\$ thousands | ||||
| Composition | 2022 | 2021 | 2022 | 2021 |
| Sale of products1 | 24,051 | 21,506 | 50,785 | 52,649 |
| Maintenance & services2 | 3,540 | 4,647 | 7,978 | 9,467 |
| Total | 27,591 | 26,153 | 58,763 | 62,116 |
1 Includes Galaxy® family recurring revenues associated with customer-owned machines.
The Group calculates the period income tax expense using the tax rate that would be applicable to the expected total annual earnings. The major components of income tax expense in the condensed interim statements of comprehensive income are:
| Group | ||||
|---|---|---|---|---|
| Six months ended December 31, | Year ended December 31, | |||
| US\$ thousands | ||||
| 2022 | 2021 | 2022 | 2021 | |
| Current tax expense | 1,484 | 756 | 2,518 | 2,261 |
| Taxes in respect of | 194 | |||
| previous years | (9) | 194 | (22) | |
| Deferred tax expense | 33 | 13 | 41 | 26 |
| Total income tax expense | 1,508 | 963 | 2,537 | 2,481 |
| December 31, 2022 | June 30, 2022 | December 31, 2021 No. of shares |
||
|---|---|---|---|---|
| No. of shares | No. of shares | |||
| Authorised: | ||||
| Ordinary shares of no par value | 2,000,000,000 | 2,000,000,000 | 2,000,000,000 | |
| Issued and fully paid: | ||||
| Ordinary shares of no par value | 356,447,895 | 355,677,875 | 355,480,480 | |
| Dormant shares (out of the issued and fully paid share capital): |
||||
| Ordinary shares of no par value | (7,509,700) | (4,967,800) | (4,390,200) | |
| Total number of issued shares (excluding dormant shares) |
348,938,195 | 350,710,075 | 351,090,280 |
For the six months ended December 31, 2022, 770,020 share options were exercised into ordinary shares. For the six months ended December 31, 2022, the Company purchased 2,541,900 of its ordinary shares at an aggregate cost of US\$ 706,000. For the year ended December 31, 2022, 967,415 share options were exercised into ordinary shares. For the year ended December 31, 2022, the Company purchased 3,119,500 of its ordinary shares at an aggregate cost of US\$ 894,000. There was no sale, transfer, disposal, cancellation and/or use of treasury shares by the Company.
As at December 31, 2022 the total number of issued shares excluding dormant shares was 348,938,195 (as at December 31, 2021- 351,090,280). As at December 31, 2022 the total number of dormant shares was 7,509,700 (as at December 31, 2021- 4,390,200). In accordance with Israeli Companies Law, Company shares that have been acquired and are held by the Company are dormant shares (treasury shares in Singaporean terms) as long as the Company holds them, and, as such, they do not bear any rights until they are transferred to a third party. The issued and fully paid shares as at December 31, 2022, June 30, 2022 and December 31, 2021 included 7,509,700, 4,967,800 and 4,390,200 dormant shares, respectively.
For the year ended December 31, 2022, the Company paid US\$ 10.5 million in dividends (an interim US\$ 1.7 million dividend in December 2022, an interim US\$ 5.3 million in September 2022 and a US\$ 3.5 million final dividend, in respect of FY2021, in May 2022). See also Note 11 – Subsequent Events.
| Average exercise price in US\$ per share |
Options | |
|---|---|---|
| At January 1, 2022 | 0.657 | 17,078,523 |
| Granted | 0.369 | 2,530,000 |
| Cancelled | 0.987 | (3,111,178) |
| Exercised | 0.168 | (967,415) |
| At December 31, 2022 | 0.572 | 15,529,930 |
During the year ended December 31, 2022, the Company granted 2,530,000 options to employees and directors under the Company's 2015 Option Plan, with vesting conditions of one to three years and a contractual life of six years. The options vest subject to service-based conditions and performance-based conditions, relating to sales targets (nil in H2 2022)
The Company measured the fair value of the share options granted using a lattice-based valuation model. The following assumptions under this method were used for the share options granted during the year ended December 31, 2022: weighted average expected volatility of: 45.87%; weighted average risk-free interest rates (in US dollar terms) of 2.44%; dividend yield of 4.48%. The weighted average fair value of the share options granted during year ended December 31, 2022 using the model was US\$ 0.113 per share option.
The calculation of basic earnings per share for the six months ended December 31, 2022 was based on the profit attributable to ordinary shareholders of US\$ 2,253,000 (six months ended December 31, 2021 -- US\$ 3,877,000) and a weighted average number of ordinary shares outstanding of 350,001,649 (six months ended December 31, 2021 – 350,912,685). The calculation of basic earnings per share for the year ended December 31, 2022 was based on the profit attributable to ordinary shareholders of US\$ 8,798,000 (2021 -- US\$ 16,456,000) and a weighted average number of ordinary shares outstanding of 350,518,378 (2021 –350,373,322), calculated as follows:
| Six months ended December 31, | Year ended December 31, | |||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| Basic earnings per share (US cents) | 0.64 | 1.10 | 2.51 | 4.70 |
| Issued ordinary shares | ||||
| at beginning of period | 350,710,075 | 349,575,676 | 351,090,280 | 349,831,926 |
| Effect of share options exercised | 536,874 | 1,347,879 | 400,081 | 732,903 |
| Effect of dormant shares purchased | (1,245,300) | (10,870) | (971,983) | (191,507) |
| Weighted average number of | ||||
| ordinary shares during period | 350,001,649 | 350,912,685 | 350,518,378 | 350,373,322 |
The calculation of diluted earnings per share for the six months ended December 31, 2022 was based on the profit attributable to ordinary shareholders of US\$ 2,253,000 (six months ended December 31, 2021 -- US\$ 3,877,000) and a weighted average number of ordinary shares outstanding after adjustment for the effects of all dilutive potential ordinary shares of 350,100,509 (six months ended December 31, 2021 -351,094,840). The calculation of diluted earnings per share for the year ended December 31, 2022 was based on the profit attributable to ordinary shareholders of US\$ 8,798,000 (2021 -- US\$ 16,456,000) and a weighted average number of ordinary shares outstanding after adjustment for the effects of all dilutive potential ordinary shares of 350,799,554 (2021 -350,867,499), calculated as follows:
| Six months ended December 31, | Year ended December 31, | |||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| Diluted earnings per share (US cents) | 0.64 | 1.10 | 2.51 | 4.69 |
| Weighted average number of | ||||
| ordinary shares (basic) | 350,001,649 | 350,912,685 | 350,518,378 | 350,373,322 |
| Effect of share options on issue | 98,860 | 182,155 | 281,176 | 494,177 |
| Weighted average number of ordinary shares (diluted) during period |
350,100,509 | 351,094,840 | 350,799,554 | 350,867,499 |
The average market value of the Company's ordinary shares for purposes of calculating the dilutive effect of share options was based on quoted market prices for the period that the options were outstanding.
| Group December 31, |
Company December 31, |
|||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| US\$ thousands | ||||
| Right-of-use assets | 3,918 | 4,719 | 3,751 | 4,450 |
| Current lease liabilities | 812 | 974 | 682 | 722 |
| Long-term lease liabilities | 3,557 | 4,743 | 3,524 | 4,625 |
| Total lease liabilities | 4,369 | 5,717 | 4,206 | 5,347 |
Maturity analysis of the Group's and Company's lease liabilities as at December 31, 2022.
| Group | Company | ||
|---|---|---|---|
| US\$ thousands | |||
| Less than one year | 812 | 682 | |
| One to five years | 2,760 | 2,727 | |
| More than five years | 797 | 797 | |
| Total lease liabilities | 4,369 | 4,206 |
The Group has lease agreements with respect to office facilities mainly in Israel and India. The Group also has lease agreements in respect to vehicles in Israel. In measurement of the lease liabilities, the Group discounted lease payments using the nominal incremental borrowing rate as at the lease inception, or at January 1, 2019 for leases in effect prior to December 31, 2018. In April 2021, the Group executed a renegotiated lease agreement for its leased office space at the Group's headquarters in Israel. Under the terms of the agreement, the leased space was downsized by approximately 30% and the financial terms were improved. Under the revised terms, the lease was extended for a period of four years, with an option for a second four-year period. As a result, for the year ended December 31, 2021, the Group recorded a non-cash gain of US\$ 267,000 in the condensed interim consolidated statements of comprehensive income.
The Group has entered into certain short-term leases for office facilities (less than 1 year). The future minimum noncancellable lease payments relating to those leases are in the amount of approximately US\$ 63,000.
On February 26, 2023, the Board of Directors recommended the Annual General Meeting approve a final dividend of US 1.0 cent per ordinary share for the full year ended December 31, 2022. Pursuant to the approval of the Annual General Meeting of the Company's shareholders to be held on April 24, 2023, the Company expects to pay a US\$ 3.5 million dividend on May 12, 2023, with record date on May 2, 2023.
On January 11, 2023, Sarine signed a non-binding memorandum of understanding to acquire a majority stake in New York's Gem Certification and Assurance Lab, Inc. (GCAL), subject to due diligence and executing a definitive agreement, in an all cash consideration. GCAL is a highly respected gemological laboratory founded in 2001. GCAL provides services for the grading and certification of natural and lab-grown diamonds, coloured diamonds, coloured gemstones, pearls and precious metals. GCAL is the only diamond and gemstone ISO 17025 Accredited Forensic Laboratory in the world. Though it has been stipulated by the parties that the terms of the deal are to remain confidential, pending its actual closing, we wish to clarify that it will not fall under the definition of a "major transaction", as per Chapter 10 of the Singapore Exchange Listing Manual.
These figures have not been audited or reviewed. The figures presented were prepared in accordance with International Financial Reporting Standards (IFRS).
Not applicable.
The same accounting policies and methods of computation adopted in the most recently audited financial statements for the financial year ended December 31, 2021 have been applied in the preparation for the financial statements for the financial year ended December 31, 2022.
Not applicable.
5. Net asset value (for the issuer and group) per ordinary share based on issued share capital of the issuer at the end of the:
(a) current financial period reported on; and
(b) immediately preceding financial year.
| Group December 31, |
Company December 31, |
|||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| Net asset value (US\$ thousands) | 67,096 | 70,551 | 67,096 | 70,551 |
| Net asset value per ordinary share: | ||||
| US cents | 19.23 | 20.09 | 19.23 | 20.09 |
| Singapore cents* | 25.86 | 27.01 | 25.86 | 27.01 |
At December 31, 2022, net asset value per share is calculated based on the number of ordinary shares in issue at December 31, 2022 of 348,938,195 (not including 7,509,700 dormant ordinary shares at December 31, 2022). At December 31, 2021, net asset value per share is calculated based on the number of ordinary shares in issue at December 31, 2021 of 351,090,280 (not including 4,390,200 dormant ordinary shares at December 31, 2021).
* Convenience translation based on exchange rate of US\$ 1=S\$ 1.3446 at December 31, 2022.
6. A review of the performance of the group, to the extent necessary for a reasonable understanding of the group's business:-
(a) any significant factors that affected the turnover, costs, and earnings of the group for the current financial period reported on, including (where applicable) seasonal or cyclical factors; and (b) any material factors that affected the cash flow, working capital, assets or liabilities of the group during the current financial period reported on.
Throughout 2022 the diamond industry faced significant global political and macroeconomic headwinds. The Ukrainian conflict in Europe affected energy and grain prices, driving inflation to exceptionally high levels in the western economies in general, and particularly in the key U.S. market. As a result, the US Federal Reserve raised interest rates aggressively to levels not seen in over a decade, negatively impacting the equities, housing and other markets and thereby eroding consumer confidence. Indeed, in the critical holiday season in the fourth quarter of 2022, retail sales dropped by some 5% year over year. In addition, in the second most important market for diamond jewellery, China, ongoing Zero-Covid pandemic-related restrictions disrupted retail activity throughout the year.
The diamond industry value chain was further impaired by the U.S. sanctions enacted in early April against Alrosa, the Russian producer, typically accounting for over 35% of the global rough diamond production. The expected shortage of rough diamonds drove their prices up throughout most of 2022 (though it is apparent, in retrospect, that Alrosa production did, in fact, mostly enter the value chain).
Concurrent with the increase in rough diamond prices, polished diamond prices in fact eroded for most of the year, commencing in the second quarter through to year's end, as the combined headwinds of inflation and interest rates took their toll on the average consumer's appetite (the demand for high-end luxury brands, mostly bought by the most affluent consumers, showed higher resiliency to the prevailing headwinds). These two divergent trends, increasing rough prices and decreasing polished prices, again manifested themselves as impaired margins for our midstream customers.
The Group reported in H2 2022, revenues of US\$ 27.6 million, profit from operations of US\$ 3.5 million, and net profit of US\$ 2.3 million, as compared to revenues of US\$ 26.2 million, profit from operations of US\$ 5.2 million, and net profit of US\$ 3.9 million reported in H2 2021. For the year ended December 31, 2022, the Group recorded revenues of US\$ 58.8 million, profit from operations of US\$ 11.0 million and net profit of US\$ 8.8 million, as compared to revenues of US\$ 62.1 million, profit from operations of US\$ 19.2 million and net profit of US\$ 16.5 million for the year ended December 31, 2021.
Overall revenues increased in H2 2022, as compared to H2 2021, on increased capital equipment sales following the introduction of the upgraded Meteorite™ Plus in September (significantly improved throughput and a reduction in the necessary operational manpower), despite weakened midstream polishing activities in H2 2022 (especially Q4 2022) that resulted in reduced recurring revenues. Nevertheless, overall revenues in FY2022 decreased, as compared to FY2021, on lower capital equipment sales (mainly in H1 2022) due to global political and macroeconomic headwinds and flattish recurring revenues (mainly from aforementioned polishing activity decline in H2 2022).
The decline in profitability in H2 2022 was mainly due to product mix, resulting in a lower gross profit margin, the overall increase in operating expenses as activities further returned to normal, and increased tax expenses, associated with a one-time repatriation of funds from our wholly owned Indian subsidiary. The decline in profitability in FY2022 was also impacted by overall lower sales.
Overall recurring revenues for H2 2022 (including Galaxy® inclusion scanning, Quazer® services, polished diamond related services, annual maintenance contracts, etc.) were approximately 48% of our overall revenue (approximately 50% for all of FY2022). Overall rough and polished diamond wholesale and retail related ("Trade") revenues, mostly from digital tenders, the Sarine Profile™ and the Sarine Diamond Journey™ were approximately 10% of our overall revenue for H2 2022 (approximately 11% for all of FY2022. We expect Trade revenues to continue growing in FY2023 from new customers and broadened adoption of our technologies.
The Group delivered 61 Galaxy®-family inclusion mapping systems in H2 2022 comprising two Galaxy® Ultra models, five Galaxy® models, 8 Meteor™ models and 46 Meteorite-plus™ and models. Only one Meteor™ systems was sold under the one-off paradigm with no follow-on per-use revenues to be generated from them in the future. As of December 31, 2022, our installed base was 803 systems.
As at December 31, 2022, cash, cash equivalents, short-term investments (bank deposits) ("Cash Balances") decreased minimally to US\$ 36.0 million as compared to US\$ 36.4 million as of December 31, 2021. The Cash Balances were primarily affected by the payment of US\$ 10.5 million in dividends (an interim US\$ 1.7 million dividend in December 2022, an interim US\$ 5.3 million in September 2022 and a US\$ 3.5 million final FY2021 dividend in May 2022) and the repurchase of US\$ 0.9 million of Sarine shares in the open market, offset by the Group's profitability in FY2022 and a slight decrease in trade receivables to US\$ 22.5 million as at December 31, 2022 (US\$23.8 million as at December 31, 2021).
Revenues for H2 2022 of US\$ 27.6 million, increased by 5%, as compared to revenues of US\$ 26.2 million reported in H2 2021. The overall increase in revenues, mainly from Africa and Europe, was due to an approximate 24% increase in capital equipment sales on the backdrop of the launch of the upgraded Meteorite™ Plus in September, offset by an approximate 9% decline in recurring revenues, manifested especially in the fourth quarter, as discussed above. Revenues for the year ended December 31, 2022 of US\$ 58.8 million, decreased by 5%, as compared to US\$ 62.1 million for the year ended December 31, 2021. The year-over-year decrease in revenues mainly from India, offset somewhat by Africa and Europe, was due to an approximate 11% decrease in capital equipment sales (mainly manifested in H1 2022) and an approximate 1% increase in recurring revenues, due to global political and macroeconomic headwinds for most of FY2022, as discussed above. The increased revenues from Africa were mainly due to increased capital equipment expenditures to develop local manufacturing capabilities, and in Europe due to our trade-related offerings.
Cost of sales for H2 2022 of US\$ 9.2 million, increased by 28% (on an increase in revenues of 5%), as compared to US\$ 7.2 million in H2 2021, with a gross profit margin of 67% in H2 2022 compared to 73% in H2 2021. The increase in cost of sales in H2 2022 was primarily due to increased capital equipment sales. The decrease in gross profit and the corresponding decrease in gross profit margin were primarily due to product mix (increased capital equipment sales and decreased recurring revenue).
Cost of sales for the year ended December 31, 2022 of US\$ 18.1 million, increased by 11% (on a decrease in revenues of 5%), as compared to US\$ 16.3 million for the year ended December 31, 2021, with a gross profit margin of 69% in FY2022 compared to 74% in FY2021. The increase in cost of sales in FY2022 was primarily due to product mix. The decrease in gross profit and the corresponding decrease in gross profit margin were primarily due to decreased overall sales and product mix. FY2021 also benefited from the sale of inventory previously written-off in prior periods.
Research and development expenses for H2 2022 of US\$ 4.5 million increased by 7% as compared to US\$ 4.2 million in H2 2021. Research and development expenses for the year ended December 31, 2022 of \$8.7 million increased by 7% as compared to US\$ 8.1 million for the year ended December 31, 2021. The increase in research and development expenses, as planned, was primarily due to higher employee costs, offset somewhat by lower outsourcing expenses.
Sales and marketing expenses for H2 2022 of US\$ 6.2 million, increased by 9%, as compared to US\$ 5.7 million in H2 2021. Sales and marketing expenses for the year ended December 31, 2022 of US\$ 12.4 million by increased 13%, as compared to US\$ 11.0 million for the year ended December 31, 2021. The increase in sales and marketing expenses was due primarily to increased advertising and trade-show related expenses, returning more closely to pre-Covid-19 levels, increased sales commissions on higher revenues outside of India and increased direct sales expenses in India and the US.
General and administrative expenses for H2 2022 of US\$ 4.2 million, increased by 6%, as compared to US\$ 4.0 million in H2 2021. General and administrative expenses for the year ended December 31, 2022 of US\$ 8.5 million, increased by 10%, as compared to US\$ 7.8 million for the year ended December 31, 2021. The increase in general and administrative expenses was primarily due to increased third-party legal and professional fees related to ongoing multiple patent and copyright litigations and related activities in India and higher provisions for bad debts in FY2022, offset somewhat by decreased incentive-based compensation accruals.
FY 2021 results benefited from a U\$ 0.3 million, non-cash gain associated with the downsizing of leased office space at the Group's headquarters in Israel in April 2021.
The Group reported a decline in profit from operations to US\$ 3.5 million in H2 2022, as compared to US\$ 5.2 million in H2 2021, and US\$ 11.0 million for the year ended December 31, 2022, as compared to US\$ 19.2 million for the year ended December 31, 2021. The decline in profit from operations in H2 2022 was mainly due to product mix, resulting in a lower gross profit margin and the overall increase in operating expenses at more normalised pre-Covid-19 spending levels, as activities further returned to normal. The decline in profitability for FY 2022 was also impacted by overall lower sales in FY2022, as detailed above.
Net finance income for H2 2022 was US\$ 0.3 million as compared to net finance expense of US\$ 0.3 million in H2 2021. Net finance income for the year ended December 31, 2022 was US\$ 0.3 million as compared to net finance expense of US\$ 0.3 million for the year ended December 31, 2021. The increase in net finance income was due to higher overall interest income during FY2022 as compared to FY2021.
The Group recorded an income tax expense of US\$ 1.5 million for H2 2022 as compared to income tax expense of US\$ 1.0 million in H2 2021. The increase in income tax expense on lower profit from operations was primarily associated with a one-time repatriation of funds from our wholly owned Indian subsidiary, resulting in an approximate one time US\$ 0.6 million charge to income tax expenses. The Group recorded an income tax expense of US\$ 2.5 million for the year ended December 31, 2022, as compared to income tax expense of US\$ 2.5 million for the year ended December 31, 2021. The flattish income tax expense was due to reduced profitability offset by the aforementioned one-time charge associated with the repatriation of funds from our wholly owned Indian subsidiary. The Group's income tax is affected by the profitability being realised in various entities of the Group, each subject to different jurisdictions, applicable incentives, and income tax loss carryforwards.
The Group reported a decline in net profit of US\$ 2.3 million in H2 2022, as compared to US\$ 3.9 million in H2 2021, and US\$ 8.8 million for the year ended December 31, 2022 as compared to US\$ 16.5 million for the year ended December 31, 2021. The decrease in net profit was mainly due to lower profit from operations, as detailed above, and the approximate US\$ 0.6 million income tax charge, also detailed above.
7. Where a forecast, or a prospect statement, has been previously disclosed to shareholders any variance between it and the actual results.
Not applicable.
We expect the following industry trends to continue influencing our business:
Barring further negative developments, we expect, as noted, that the reopening of the Chinese market will drive renewed demand and revitalise the diamond value chain in its entirety, including the midstream polishing segment, key to our business.
We will focus on the following objectives in 2023:
On February 26, 2023, the Board of Directors recommended that the Annual General Meeting (AGM) approve a final dividend of US 1.0 cent per ordinary share for the financial year ended December 31, 2022. This will bring our total payout for FY2022 to some US\$ 10.5 million, if approved at the AGM.
On February 27, 2022, the Board of Directors recommended that the Annual General Meeting (AGM) approve a final dividend of US 1.0 cent per ordinary share for the financial year ended December 31, 2021.
| Tax rate applicable | ||
|---|---|---|
| Amount before tax | to shareholders | |
| US\$ thousands | Percent | |
| 2022 | 3,489 | 20%/0%1 / 10%2,3 |
| 2021 | 3,511 | 20%/0%1 / 10%2,3 |
1 The tax rate will be 20% (20% in 2021) for individual Israeli shareholders and 0% (0% in 2021) for Israeli corporate shareholders.
2 The tax rate for the dividends for individual and corporate Singaporean shareholders is 10% (10% in 2021. 3 Payments to shareholders of dividends distributed by the Company will be subject to a tax deduction at source at the rate of 20%, in compliance with Israeli tax directives. Tax amounts deducted from dividend payments will be deposited with a trustee. A shareholder claiming eligibility for preferential tax treatment on dividend payments pursuant to Israeli tax laws or international tax treaties may apply to the trustee within 30 days of the distribution date providing all necessary details and documents, for reimbursement of excess deduction, subject to verification of such eligibility. Details regarding the application procedure shall be provided by the Company in the formal dividend announcement posted on the SGX.
| Amount | |
|---|---|
| US\$ thousands | |
| 12 May 2023*** | 3,489 |
| 19 May 2022 | 3,511 |
5:00 PM on:
| Amount | |
|---|---|
| US\$ thousands | |
| 02 May 2023*** | 3,489 |
| 09 May 2022 | 3,511 |
***Pending Annual General Meeting Approval
Not applicable.
The Group has not obtained a general mandate from its shareholders for IPTs.
Not applicable.
The Company confirms that it has procured undertakings from all its Directors and Executive Officers in the format set out in Appendix 7.7 under Rule 720 (1) of the Listing Manual.
14. Segmented revenue and results for business or geographical segments (of the Group) in the form presented in the issuer's most recently audited annual financial statements, with comparative information for the immediately preceding year.
In accordance with IFRS 8 Operating Segments, the Group determines and presents operating segments based on the information that internally is provided to the CEO, who is the Group's chief operating decision maker. The Group operates in only one operating segment. Presented below are revenues broken out by geographic distribution.
| Africa | Europe | USA | Israel | Others | Consolidated | ||
|---|---|---|---|---|---|---|---|
| 2022 | |||||||
| US\$ thousands | |||||||
| External revenues | 30,309 | 13,692 | 3,502 | 842 | 2,227 | 8,191 | 58,763 |
| Unallocated expenses | (47,765) | ||||||
| Profit from operations | 10,998 | ||||||
| Net finance income | 337 | ||||||
| Income tax expense | (2,537) | ||||||
| Profit for the year | 8,798 | ||||||
| India | Africa | Europe | USA | Israel | Others | Consolidated | |
| External revenues | 40,540 | 8,171 | 1,858 | 1,115 | 2,653 | 7,779 | 62,116 |
| Unallocated expenses | (42,913) | ||||||
| Profit from operations | 19,203 | ||||||
| Net finance expense | (266) | ||||||
| (2,481) | |||||||
| Income tax expense | |||||||
| 2021 US\$ thousands |
15. In the review of performance, the factors leading to any material changes in contributions to turnover and earnings by the business or geographical segments.
See section 6 above.
| 2022 | 2021 | |||
|---|---|---|---|---|
| US\$ thousands | ||||
| Revenue reported for: | ||||
| First half-year ended 30 June | 31,172 | 35,963 | ||
| Second half-year ended 31 December | 27,591 | 26,153 | ||
| 58,763 | 62,116 | |||
| Profit for the period: | ||||
| First half-year ended 30 June | 6,545 | 12,579 | ||
| Second half-year ended 31 December | 2,253 | 3,877 | ||
| 8,798 | 16,456 |
| Latest Full Year | Previous Full Year | ||||
|---|---|---|---|---|---|
| US\$ thousands | |||||
| Ordinary | 10,492* | 8,780 |
*Pending Annual General Meeting Approval.
The Company confirms that, during the year ended December 31, 2022, there was no person occupying any managerial position in the Company or any of its subsidiaries who is a relative of a director or chief executive officer or substantial shareholder of the Company.
The Company confirms that during the year ended December 31, 2022, the Company was not a party to any interested person transactions.
On behalf of the Directors
Daniel Benjamin Glinert Executive Chairman
26 February 2023
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.